Trahair, L G
Marathe, C S
Standfield, S
Rayner, C K
Feinle-Bisset, C
Horowitz, M
Jones, K L
Article History
Received: 28 May 2016
Revised: 10 August 2016
Accepted: 30 September 2016
First Online: 6 December 2016
Competing interests
: MH has participated in the advisory boards and/or symposia for Novo Nordisk, Sanofi, Novartis, Eli Lilly, Merck Sharp and Dohme, Boehringer Ingelheim and AstraZeneca, and has received honoraria for this activity. CKR has received research funding from Merck, AstraZeneca and Novartis. The remaining authors declare no conflict of interest.